This case study demonstrates how DelveInsight supported an oncology-focused pharmaceutical client in assessing investment opportunities in IL-2 therapies.

Before marketers learn AI, or the language of the boardroom, or purpose, or storytelling, or any of the other things we keep ...

AMD’s upcoming Medusa Point APU lineup continues to surface in software updates, and the latest LLVM compiler changes reveal ...

Hypertension impacts a significant share of the global population and remains a leading cause of cardiovascular morbidity and ...

After over 25 years in marketing, I learned that many targeting decisions aren't driven by sound commercial logic. Here are ...

The global automotive cybersecurity market is growing rapidly, expected to be valued at around US$ 4,050.3 million ...

The client recognized that without a comprehensive, country-level understanding of the patient journey, commercial strategies could become misaligned with real-world patient and provider needs, potent ...

Through advanced analytics, marketing scientists can determine the casual relationship between content, consumer perception ...

Q4 2025 earnings call: gedatolisib NDA priority review, VIKTORIA-1 data and launch plans ahead of July 2026 PDUFA—read now.

Shares for On Holding fell more than 11 percent on Wednesday.

Vado has developed a nuanced view that campaign performance reflects an interplay of data quality, human strategy, and ...